Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs111505600 | chr5:74352615 | T/A | 1.94E-14 | 130 | 43.68 | 39.23 | 4.92 | KM Plot |
| TGCT | rs11153626 | chr6:117071569 | G/A | 0.00014 | 131 | 43.68 | 37.65 | 34.7 | KM Plot |
| TGCT | rs111935448 | chr16:30919807 | C/T | 1.72E-13 | 132 | 39.38 | 81.3 | 17.1 | KM Plot |
| TGCT | rs112085062 | chr2:29494057 | T/C | 0 | 134 | 42.27 | 25.02 | 0.57 | KM Plot |
| TGCT | rs112104474 | chr2:29506828 | T/G | 0 | 134 | 42.27 | 25.02 | 0.57 | KM Plot |
| TGCT | rs112124352 | chr5:74424591 | G/A | 3.22E-14 | 129 | 43.68 | 32.37 | 4.92 | KM Plot |
| TGCT | rs112181044 | chr6:28329677 | C/T | 0 | 134 | 45.83 | 29.65 | 0.57 | KM Plot |
| TGCT | rs112249387 | chr6:157022967 | C/CA | 0.000125 | 133 | 40.57 | 64.8 | 59.27 | KM Plot |
| TGCT | rs11236166 | chr11:70251812 | A/G | 8.12E-6 | 134 | 45.83 | 36.1 | 47.13 | KM Plot |
| TGCT | rs112464447 | chr19:37311663 | T/C | 0 | 130 | 38.2 | 55.8 | 0.57 | KM Plot |
| TGCT | rs11250252 | chr10:1124939 | G/C | 2.26E-13 | 132 | 42.03 | 66.9 | 17.1 | KM Plot |
| TGCT | rs11250264 | chr10:1151723 | A/C | 1.35E-13 | 134 | 42.03 | 66.9 | 17.1 | KM Plot |
| TGCT | rs11250274 | chr10:1171354 | T/C | 2.86E-13 | 131 | 40.57 | 66.9 | 17.1 | KM Plot |
| TGCT | rs11250275 | chr10:1171823 | A/G | 1.36E-13 | 134 | 17.1 | 66.9 | 42.03 | KM Plot |
| TGCT | rs112528318 | chr5:74581395 | A/G | 2.0E-5 | 127 | 45.1 | 28.8 | 9.27 | KM Plot |